↓ Skip to main content

Osteonecrosis of the jaw in a Crohn’s disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report

Overview of attention for article published in BMC Gastroenterology, January 2014
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
101 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Osteonecrosis of the jaw in a Crohn’s disease patient following a course of Bisphosphonate and Adalimumab therapy: a case report
Published in
BMC Gastroenterology, January 2014
DOI 10.1186/1471-230x-14-6
Pubmed ID
Authors

Raimund HM Preidl, Tobias Ebker, Martin Raithel, Falk Wehrhan, Friedrich W Neukam, Philipp Stockmann

Abstract

Bisphosphonates have a widespread indication for osteoporosis and are also applied in cancer patients with skeletal-related conditions. Bisphosphonate-associated osteonecrosis of the jaw (BRONJ) is a feared side effect which is hard to treat and often affects patient's quality of life in an extensive manner. Adalimumab (Humira®), a fully human recombinant antibody specific for tumor necrosis factor- α, is approved for treatment in patients with Inflammatory Bowel Disease like ulcerative colitis or Crohn's disease.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 101 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Unknown 100 99%

Demographic breakdown

Readers by professional status Count As %
Student > Postgraduate 13 13%
Student > Master 13 13%
Other 12 12%
Researcher 10 10%
Student > Bachelor 7 7%
Other 21 21%
Unknown 25 25%
Readers by discipline Count As %
Medicine and Dentistry 56 55%
Agricultural and Biological Sciences 5 5%
Psychology 3 3%
Nursing and Health Professions 3 3%
Arts and Humanities 1 <1%
Other 7 7%
Unknown 26 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 January 2014.
All research outputs
#20,216,580
of 22,739,983 outputs
Outputs from BMC Gastroenterology
#1,359
of 1,737 outputs
Outputs of similar age
#264,248
of 304,743 outputs
Outputs of similar age from BMC Gastroenterology
#25
of 26 outputs
Altmetric has tracked 22,739,983 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,737 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 304,743 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.